MemoHoney Medical Review Policy: What Gets Checked, by Whom, and How

Memoqhoney is the MemoHoney authorized U.S. retailer, with an office at 1500 Broadway in New York and a separate returns address. It holds stock, writes these pages and sends buyers to the seller’s own checkout. It does not make, blend or bottle the capsule.

The MemoHoney Team writes every page. The physician the seller’s pack names, Dr. Aimee Duffy, MD, reviews them. Both names appear in the strip at the top of the home page, in the file at the foot of every page and on the about page.

1. Does every figure have a source? A trial dose, an upper limit or a price must trace to a linked record or the seller’s page.
2. Does any sentence outrun the bottle? The bottle says Advanced Memory Support, with Focus, Clarity and Energy; nothing on a page may claim more.
3. Would a reader who should see a doctor be told so? New or worsening memory problems, sudden confusion and medicine interactions are flagged wherever they matter.
4. Is the safety wording plain? The one-capsule limit, the niacin ceiling and the blood-pressure note must read clearly to someone in a hurry.

A page that fails any of the four goes back to the writer. It is published only when all four pass, and its revision date is set that day.

It is not a consultation. Dr. Aimee Duffy, MD does not know you, your history or your prescriptions, and a reviewed web page is no substitute for that conversation.

It is not an endorsement. A physician confirming that a page is accurate is not recommending the product it describes.

It is not a test of the capsule. The review reads words and numbers on a page; it does not analyse what is inside a bottle.

1. The bottle artwork. The six named actives, the capsule count, the directions and the label claim. If your bottle differs, your bottle wins.
2. The seller’s product page and checkout. Packs, prices, shipping and the 60-day refund terms. The checkout was opened again on 1 October 2026 and matched the prices printed here: two bottles $158, three $207, six $294.
3. Public health agencies. NIH’s Office of Dietary Supplements, the National Institute on Aging, MedlinePlus, NCCIH, the CDC, the FDA and the FTC.
4. Published trials. Each study is pulled from PubMed by its PMID and read against the record before it is cited. None of them tested MemoHoney.

The artwork this site was supplied names ingredients without amounts. The pages say so in the sections that deal with dose, and they place the amounts the trials used beside each name rather than inventing a figure.

• No page says MemoHoney prevents, slows or treats memory loss, dementia or cognitive decline.
• No page repeats the seller’s stronger lines, such as protecting the brain from oxidative stress, as findings; they are quoted once, as the seller’s words.
• No page calls a seal an approval. The FDA does not approve dietary supplements before they are sold (FDA).
• No page promises a result by a set week. The 3 to 4 weeks quoted is what buyers here report, and some report nothing.

These limits follow the FTC’s guidance on health products and the FDA’s page on structure and function claims.

• Memory problems that are new, worsening or noticed by others are sent to a doctor, citing the National Institute on Aging.
• Sudden confusion, slurred speech or weakness on one side is written as a 911 call (CDC).
• Blood-pressure medicines, nitrates and PDE5 inhibitors are named because four of the actives act through nitric oxide.
• The niacin ceiling of 35 mg a day from supplements is repeated where dose is discussed (NIH ODS).

The complete list of situations that call for a doctor first is in the disclaimer.

Review figures. The 4.7 average, the 1,065 write-ups, the 7,248 orders and the 91% recommending come from the seller’s own tally. Nobody here has audited them, and the pages say so wherever they appear.

Prices. The seller sets them; the pages show the date they were checked. The struck figures beside them ($358, $537, $1,074) are the seller’s comparison prices.

Codes. Lot MEM-26/ME-1612 and certificate reference MEM-1612-26-ME are filing references for the stock this desk holds. They are not laboratory results.

The editorial score. The marks out of ten on the home page are this desk’s own judgement, each with its reason printed beside it.

Each page shows a revision date in its byline and again in the file at its foot, and the same date sits in the page’s structured data. It changes when the content changes: a new price on the checkout, a revised bottle, a new review of one of the six actives, or a reader’s correction. Prices also carry the date they were last checked against the checkout.

A changed page goes back through the same medical review before it replaces the old version. A date is never moved simply to make a page look newer than it is.

Memoqhoney earns a commission when a pack is ordered through the buttons on this site. Those links are tagged as sponsored, they open the seller’s checkout, and the price is whatever that checkout shows. This site never takes card details.

The order desk in the footer handles tracking, changes and refunds once an order exists. It is not a route for placing one.

Write to the website inbox listed in the footer with the page address and the sentence you think is wrong. If it concerns a citation, the PMID helps; if it concerns the bottle, a photograph of yours helps more. The desk checks it against the record or the label, and a confirmed error is fixed on the page where it sits, with the revision date moved.

September 30, 2026. The byline and the foot of every page now name the medical reviewer; a see-a-doctor-first section was added to the disclaimer; phone and email details moved to the footer and the contact page; the review score left the top of the home page; and this policy was published.